Thomas Helton

Thomas Helton is currently the Chief Operating Officer at EvE Bio, where Thomas leads research initiatives to map the pharmome. Prior to this, Thomas was a Sr. Research Associate at the National Institute of Environmental Health Sciences, focusing on synaptic diversity in hippocampal neurons. Thomas also worked as a Principal Scientist at Pfizer, researching inheritable risk factors in schizophrenia and bipolar disorder. With a strong background in cell biology and molecular biology, Thomas has also held positions at Brown University and Duke University, focusing on voltage-gated calcium channels and excitatory synapses.